Adding ibrutinib to rituximab improved outcomes in patients with previously untreated FL who were ineligible for CIT.

The monoclonal antibody rituximab (Rituxan) is the maintenance therapy doctors often prescribe for follicular lymphoma. This drug seeks out and attaches to a protein called CD20 on the outside of ...

Thus, patients in the rituximab induction and maintenance groups were significantly less likely to start new treatment versus those in the watchful waiting group: Induction: HR 0.55 (95% CI 0.38-0.80) ...

The updated results of an international phase III randomized study comparing rituximab maintenance therapy with observation in 465 patients with relapsed follicular lymphoma were reported by van ...

Even though follicular lymphoma responds well to treatment, it’s likely to return, or relapse. You’ll need more treatment. But between courses, you're likely to feel well for long stretches.

ATLANTA -- Patients with newly diagnosed low-burden follicular lymphoma (FL) in remission avoided chemotherapy significantly longer if they received maintenance rituximab (Rituxan) instead of ...

Rituximab, a monoclonal anti-CD20 antibody, in combination with chemotherapy improves overall survival compared to chemotherapy alone when used for induction therapy for patients with newly diagnosed ...

Revlimid plus rituximab is the first chemotherapy-free combination regimen approved in Europe for patients with follicular lymphoma who have relapsed or did not respond to previous treatment ...

Rituximab maintenance following induction immunochemotherapy conferred durable PFS compared with observation among patients with follicular lymphoma, according to long-term results of the ...

HealthDay News — Rituximab plus lenalidomide has similar efficacy to rituximab plus chemotherapy among patients with previously untreated follicular lymphoma, according to a study published in ...

RESULTS OF THE PHASE 3 GALLIUM STUDY , which compared the safety and efficacy of rituximab and obinutuzumab as first-line treatments for patients with previously untreated follicular lymphoma (FL ...